Newsletter | February 21, 2025

02.21.25 -- Exploring Next Generation Oncology Research

NEW PODCAST EPISODE

Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali

Discover the future of cardiac care on Cell & Gene: The Podcast as host Erin Harris speaks with Faraz Ali, CEO of Tenaya Therapeutics. They dive into groundbreaking gene therapies for heart disease, Tenaya’s innovative platform, and their in-house manufacturing capabilities. Ali shares insights on commercialization challenges, industry trends, and what’s ahead for Tenaya in 2025. Tune in for a fascinating look at how gene therapy is transforming heart disease treatment.

FEATURED PODCAST

3T Bioscience's CEO Stefan Scherer MD, Ph. D, On Next Generation Oncology Research

Dr. Scherer’s commitment to oncology patients took him from medical practice to research to helming 3T Biosciences, which is developing a novel T cell targeting platform.

INDUSTRY INSIGHTS

CRO Summit Seeks To Boost Collaboration Between Sponsors And CROs

The inaugural CRO Summit in Raleigh gathered 200+ attendees to enhance sponsor-CRO collaboration, explore technology integration, and discuss AI’s cautious adoption in clinical trials.

How Approved Drugs Have Evolved Since The '70s

Drugs have become more lipophilic and complex in structure over time. Innovative strategies are needed to improve the bioavailability of these new drugs.

Evolution Of ERP In Biotech And Integration Challenges

Consolidating various software systems enables efficient management of direct fees, pass-throughs, and investigator grants within a single platform, providing a complete view of your trials' financial health.

Β-Glucan As A Process-Related Impurity In Biopharmaceuticals

In this white paper, we dig deeper into the sources of Β-glucan, its influence on manufacturing and patient safety, and ways to detect and control its amounts in the finished drug product.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.